Research
All Research Featured Research
White Paper
Prospects for Future Advances in Alzheimer’s Disease
August 18, 2020
Featured Experts: Jakub Hlávka, PhD, Dana Goldman, PhD
News
Due to Complex Barriers, the Overwhelming Majority of Alzheimer’s Patients Do Not Participate in Clinical Trials
August 17, 2020
Featured Experts: Dana Goldman, PhD, Julie Zissimopoulos, PhD, Paul Aisen, MD
White Paper
Key Barriers for Clinical Trials for Alzheimer’s Disease
August 17, 2020
Featured Experts: Dana Goldman, PhD, Niranjan Bose, PhD
Perspective
Yes, We Need a Vaccine to Control COVID-19. But We Need New Treatments, Too.
August 5, 2020
Featured Experts: Karen Mulligan, PhD, Karen Van Nuys, PhD
News
Coronavirus Treatments, Not Just Vaccines, Will Save Lives and Generate Value
July 9, 2020
Featured Experts: Karen Mulligan, PhD, Karen Van Nuys, PhD, Desi Peneva, MS, Geoffrey Joyce, PhD
White Paper
The Value of Treatment for COVID-19
July 8, 2020
Featured Experts: Karen Mulligan, PhD, Karen Van Nuys, PhD, Desi Peneva, MS, Geoffrey Joyce, PhD
Evidence Base
California Leads in Public Investment in Biomedical Innovation and It Is Beginning to Show Returns
July 1, 2020
Featured Experts: Dana Goldman, PhD
News
Schaeffer Study Shows Public Investment in Stem Cell Research Makes Economic Sense
June 24, 2020
Featured Experts: Dana Goldman, PhD, Bryan Tysinger, PhD
White Paper
The Economic Case for Public Investment in Stem Cell Research
June 24, 2020
Featured Experts: Dana Goldman, PhD, Bryan Tysinger, PhD
White Paper
Health Technology Assessment for the U.S. Healthcare System
February 26, 2020
Featured Experts: Karen Mulligan, PhD, Darius Lakdawalla, PhD, Dana Goldman, PhD, Jakub Hlávka, PhD, Desi Peneva, MS
Journal Article
Economic Value of Anti–Vascular Endothelial Growth Factor Treatment for Patients With Wet Age-Related Macular Degeneration in the United States
November 14, 2019
Featured Experts: Karen Mulligan, PhD, Seth Seabury, PhD, Dana Goldman, PhD
News
Treatments for the Leading Cause of Blindness in the US Generate $0.9 to $3 Billion for Society, According to New Economic Analysis
November 14, 2019
Featured Experts: Karen Mulligan, PhD, Seth Seabury, PhD, Dana Goldman, PhD
Perspective
CBO Estimate on Pelosi Drug Bill Misses its Long-Term Impact on Health
October 16, 2019
Featured Experts: Dana Goldman, PhD
News
Newly Approved Cancer Drugs Are Pricey, But Also Show Improved Longer-Term Survival Gains
October 7, 2019
Featured Experts: Alice Chen, PhD, Dana Goldman, PhD
Perspective
Here’s How We Can Control Drug Costs While Spurring Innovation
June 15, 2019
Featured Experts: Dana Goldman, PhD
News
Research Spotlight: Alzheimer’s Disease
June 11, 2019
Featured Experts: Julie Zissimopoulos, PhD, Dana Goldman, PhD, Geoffrey Joyce, PhD
Book
Economic Dimensions of Personalized and Precision Medicine
April 20, 2019
Featured Experts: Dana Goldman, PhD
Issue Brief
Redefining Value in Cancer Care
August 30, 2018
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD, John Romley, PhD, Seth Seabury, PhD